A Pilot Phase IB trial of PSA-Peptide Based Specific Active Immunotherapy

$45,027M01FY2004RRNIH

University Of Illinois At Chicago, Chicago IL

Investigators

Linked publications & trials

Paper 37450064 Paper 35810825 Paper 35746879 Paper 33222764 Paper 32578483 Paper 32576601 Paper 32503932 Paper 32387023 Paper 32205410 Paper 31732235 Paper 31714343 Paper 31668375 Paper 30137494 Paper 25336939 Paper 24994556 Paper 24707449 Paper 24219913 Paper 23530302 Paper 23520040 Paper 23489677 Paper 23389416 Paper 23344473 Paper 22980963 Paper 22965589 Paper 22841929 Paper 22735028 Paper 22727724 Paper 22658574 Paper 22516527 Paper 22497791 Paper 22465315 Paper 22446176 Paper 22432455 Paper 22339488 Paper 22265362 Paper 22153804 Paper 22136096 Paper 22106226 Paper 22004983 Paper 21896829 Paper 21787982 Paper 21783289 Paper 21705121 Paper 21673295 Paper 21633409 Paper 21592741 Paper 21430075 Paper 21426455 Paper 21418452 Paper 21389978 Paper 21187260 Paper 21074774 Paper 20973710 Paper 20949318 Paper 20868458 Paper 20858565 Paper 20847142 Paper 20816040 Paper 20660819 Paper 20569726 Paper 20543752 Paper 20389058 Paper 20303462 Paper 20299372 Paper 20233179 Paper 20073150 Paper 20019670 Paper 19922049 Paper 19595703 Paper 19541818 Paper 19364393 Paper 19357842 Paper 19344199 Paper 19232025 Paper 19015288 Paper 18503498 Paper 18455727 Paper 18357574 Paper 18273603 Paper 18246984 Paper 18208632 Paper 17961988 Paper 17667485 Paper 17427242 Paper 17321580 Paper 17208254 Paper 17164813 Paper 17118992 Paper 17018654 Paper 16887471 Paper 16768641 Paper 16611280 Paper 16476735 Paper 16407737 Paper 16283303 Paper 16210053 Paper 16107963 Paper 16085678 Paper 16046743 Paper 15920000

View original record on NIH RePORTER →

A Pilot Phase IB trial of PSA-Peptide Based Specific Active Immunotherapy · GrantIndex